Metformin Does Not Affect Clinically Relevant Outcomes in Patients with Idiopathic Pulmonary Fibrosis
Conclusions: Metformin has no effect on clinically relevant outcomes in patients with IPF.Respiration
Source: Respiration - Category: Respiratory Medicine Source Type: research
More News: Diabetes | Diabetes Mellitus | Endocrinology | Fortamet | Metformin | Respiratory Medicine | Study